Vincent Medical Holdings Limited provided consolidated earnings guidance for the year ended 31 December 2022. For the year, the company is expected to record an unaudited consolidated net loss attributable to owners of the Company within the range of HKD 15.0 million to HKD 20.0 million, as compared to an audited consolidated profit attributable to owners of the Company of approximately HKD 60.7 million for the year ended 31 December 2021.
Vincent Medical Holdings Limited
Equities
1612
KYG9367D1025
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 HKD | -1.30% | 0.00% | -1.30% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.30% | 32.13M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 1612 Stock
- News Vincent Medical Holdings Limited
- Vincent Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022